Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Boehringer Ingelheim
Cipla
AstraZeneca
Fuji
Chubb
McKesson
Express Scripts

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075475

« Back to Dashboard

NDA 075475 describes LEVOBUNOLOL HYDROCHLORIDE, which is a drug marketed by Alcon Labs Inc, Apotex Inc, Bausch And Lomb, and Sandoz Inc, and is included in six NDAs. It is available from three suppliers. Additional details are available on the LEVOBUNOLOL HYDROCHLORIDE profile page.

The generic ingredient in LEVOBUNOLOL HYDROCHLORIDE is levobunolol hydrochloride. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
Summary for 075475
Tradename:LEVOBUNOLOL HYDROCHLORIDE
Applicant:Apotex Inc
Ingredient:levobunolol hydrochloride
Patents:0
Therapeutic Class:Ophthalmic Agents
Medical Subject Heading (MeSH) Categories for 075475

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength0.5%
Approval Date:Aug 3, 2000TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
US Army
QuintilesIMS
Farmers Insurance
Moodys
Healthtrust
Accenture
Fuji
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.